Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
about
Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signalingCD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interestAmyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent mannerPADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.Molecular regulation of tumor angiogenesis and perfusion via redox signaling.Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.Blockade of CD47 increases survival of mice exposed to lethal total body irradiationThrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.Silencing of CD47 and SIRPα by Polypurine reverse Hoogsteen hairpins to promote MCF-7 breast cancer cells death by PMA-differentiated THP-1 cellsEffect and mechanism of thrombospondin-1 on the angiogenesis potential in human endothelial progenitor cells: an in vitro studyThrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice.The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation.Identification of TAX2 peptide as a new unpredicted anti-cancer agent.CD47 deficiency confers cell and tissue radioprotection by activation of autophagy.Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapiesThrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.Thrombospondin-1/CD36 pathway contributes to bone marrow-derived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression.Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.Thrombospondins: old players, new gamesThrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.Stimulating Fracture Healing in Ischemic Environments: Does Oxygen Direct Stem Cell Fate during Fracture Healing?Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.Nitric oxide: what's new to NO?Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstrictionThrombospondins function as regulators of angiogenesis.CD47
P2860
Q24627155-34C1552C-B2C7-4D03-B831-C45B513566D2Q24657627-3899CA83-33B7-4BB2-A5F0-7F2CA98FE3B2Q28270624-730536F8-5780-488B-9DEC-2214B2818694Q28476620-F3E71234-DF4C-4158-BA2B-3004E5818AB3Q30279209-5766BEF1-1591-48A2-AFE9-FAB068DAA80FQ33572306-995B2A12-7A17-4A2E-9F29-62839273826CQ33660552-5D6782F5-9D50-4B9A-B66B-1F6F6C33ACCBQ33772904-CC290B77-CE22-4DEA-BF6E-824BA3DC528DQ34321730-83A808D8-C61B-442F-BB8E-3C5C89DAD283Q34385843-1AAE8640-83FD-4A01-9B36-C6670668655EQ34516854-7ADD2781-F6E7-4941-B53E-498E48EC5B17Q34541210-1705E83B-140C-43E9-ADAA-574D29CCC10CQ35088607-2CD52BAB-2C38-439A-9D28-4B6069FDC613Q35170952-8FA2C2C9-B17C-404C-8F03-2234A497DBBBQ35809576-01BED625-81A7-4385-9753-207D0025FCFAQ36011859-8BE9F467-9E8D-49DF-9754-0BE611FAE28DQ36228487-FFCCC65F-A95C-4A63-96FF-56DF25D79513Q36388432-D4277246-BD65-4A0A-8175-C4DBC4BB5243Q36955405-2F1A4E8A-767D-417D-8310-D777C192C937Q37036482-0824010A-7DB1-4506-B43A-E28A4B971E6AQ37385797-B1AEE952-126A-428C-9D94-EE52551DC78AQ37400455-CC3F9E7E-E9EC-4281-AC00-62C7E113C82DQ37439793-3AADEE6F-3272-4C59-8726-ADF939EE125FQ37477176-10329465-DFA4-4023-9F52-9DC833786B83Q37697630-0686EA2C-E446-4009-8789-579B11321883Q38124703-6963F4AC-8766-440E-8636-EBBDE4AECB33Q38177946-BC7A04BB-CEAA-48E4-86DB-0592C064767EQ38775706-D85DA522-974B-4121-BE77-058A4F447783Q38830839-209DC5F2-0677-4603-A504-7AC39824E728Q39038560-1A8E23F7-B13D-4B35-8045-96609CE0627FQ39284030-7DAEDB7F-DC20-4B69-B984-3EA3B1693262Q40390084-BE1C2E0C-7A9A-4C19-836F-3250F9F7B717Q42643939-D673D952-1B14-4B63-B64C-46C550447363Q56592275-366B04AD-3890-484E-AF3F-F21704D50DA4
P2860
Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Gene silencing of CD47 and ant ...... mplications for human disease.
@ast
Gene silencing of CD47 and ant ...... mplications for human disease.
@en
type
label
Gene silencing of CD47 and ant ...... mplications for human disease.
@ast
Gene silencing of CD47 and ant ...... mplications for human disease.
@en
prefLabel
Gene silencing of CD47 and ant ...... mplications for human disease.
@ast
Gene silencing of CD47 and ant ...... mplications for human disease.
@en
P2093
P2860
P1433
P1476
Gene silencing of CD47 and ant ...... mplications for human disease.
@en
P2093
David D Roberts
Jeff S Isenberg
Jeremy Smedley
Justin B Maxhimer
Martin J Romeo
William A Frazier
P2860
P304
P356
10.1097/SLA.0B013E31816C4006
P407
P577
2008-05-01T00:00:00Z